Literature DB >> 3298300

Urinary and serum electrolytes in untreated black and white hypertensives. Veterans Administration Cooperative Study Group on Antihypertensive Agents.

.   

Abstract

Twenty-four hour urinary excretion of sodium (Na), potassium (K), Na/K ratio and creatinine (Cr), serum Cr, Na, and K, and plasma renin activity (PRA) were evaluated in 623 untreated hypertensive men. Blacks (n = 407) and whites (n = 216) were similar in weight, heart rate, systolic blood pressure (SBP), diastolic blood pressure (DBP), 24-hour urine Cr excretion, and Cr clearance. Twenty-four hour urine Na excretion was the same in blacks and whites, but whites excreted 62% more K than blacks: 73 +/- 41 (mean +/- SD) vs 45 +/- 40 mEq/24h (p less than 0.001). Urinary Na/K ratio was 4.51 +/- 2.18 in blacks and 2.85 +/- 1.40 in whites (p less than 0.001). Serum K and PRA were also lower in blacks. Serum and urine Na/K ratios, serum Na and age were positively associated with SBP; serum K and PRA were negatively associated with SBP. Serum Na/K ratio, heart rate and weight were positively associated with DBP; serum K was weakly negatively associated with DBP. The racial difference in urinary K excretion and serum K is believed to reflect a difference in dietary K intake between blacks and whites. This difference may be an important factor in the greater prevalence of hypertension among blacks.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3298300     DOI: 10.1016/0021-9681(87)90183-4

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  11 in total

1.  Race, Serum Potassium, and Associations With ESRD and Mortality.

Authors:  Yan Chen; Yingying Sang; Shoshana H Ballew; Adrienne Tin; Alex R Chang; Kunihiro Matsushita; Josef Coresh; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Morgan E Grams
Journal:  Am J Kidney Dis       Date:  2017-03-28       Impact factor: 8.860

2.  Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race.

Authors:  John Hayes; Kamyar Kalantar-Zadeh; Jun L Lu; Sharon Turban; John E Anderson; Csaba P Kovesdy
Journal:  Nephron Clin Pract       Date:  2011-12-02

Review 3.  Trends in 24-h urinary sodium excretion in the United States, 1957-2003: a systematic review.

Authors:  Adam M Bernstein; Walter C Willett
Journal:  Am J Clin Nutr       Date:  2010-09-08       Impact factor: 7.045

4.  Association of renin and aldosterone with ethnicity and blood pressure: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Dena E Rifkin; Ali R Khaki; Nancy S Jenny; Robyn L McClelland; Matthew Budoff; Karol Watson; Joachim H Ix; Matthew A Allison
Journal:  Am J Hypertens       Date:  2014-01-16       Impact factor: 2.689

Review 5.  New insights on the risk for cardiovascular disease in African Americans: the role of added sugars.

Authors:  Karim R Saab; Jessica Kendrick; Joseph M Yracheta; Miguel A Lanaspa; Maisha Pollard; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 10.121

6.  Racial differences in urinary potassium excretion.

Authors:  Sharon Turban; Edgar R Miller; Brett Ange; Lawrence J Appel
Journal:  J Am Soc Nephrol       Date:  2008-06-25       Impact factor: 10.121

Review 7.  Racial and ethnic differences in hypertension.

Authors:  Deborah S Minor; Marion R Wofford; Daniel W Jones
Journal:  Curr Atheroscler Rep       Date:  2008-04       Impact factor: 5.113

Review 8.  Does socioeconomic status affect blood pressure goal achievement?

Authors:  Deborah Minor; Marion Wofford; Sharon B Wyatt
Journal:  Curr Hypertens Rep       Date:  2008-10       Impact factor: 5.369

Review 9.  Race and hypertension. What is clinically relevant?

Authors:  D R Rutledge
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

Review 10.  Meeting the challenge to improve the treatment of hypertension in blacks.

Authors:  Antonio Alberto Lopes; Sherman A James; Friedrich K Port; Akinlolu O Ojo; Lawrence Y Agodoa; Kenneth A Jamerson
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Nov-Dec       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.